The Integration of Chemotherapy and Surgery for Bladder Cancer

Restricted access

Despite surgery with curative intent, approximately 50% of patients with muscle-invasive transitional cell carcinoma of the bladder will develop distant metastases and succumb to their disease. Attempts to improve outcomes have focused on refining surgical techniques and integrating perioperative chemotherapy. This review summarizes the available literature addressing the role of pelvic lymphadenectomy, neoadjuvant chemotherapy, and adjuvant chemotherapy in the management of patients with muscle-invasive transitional cell carcinoma of bladder.

Correspondence: Matthew Galsky, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. E-mail: Galskym@mskcc.org
  • 1

    SteinJPLieskovskyGCoteR. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol2001;19:666675.

    • Search Google Scholar
    • Export Citation
  • 2

    ViewegJGschwendJEHerrHW. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol1999;161:449454.

    • Search Google Scholar
    • Export Citation
  • 3

    ViewigJWhitmoreWFHerrH. The role of pelvic lympadenectomy and radical cystectomy for lymph node positive bladder cancer: The Memorial Sloan-Kettering Cancer Center experience. Cancer1994;73:30203028.

    • Search Google Scholar
    • Export Citation
  • 4

    HerrHW: Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality). BJU Int2003;92:187188.

  • 5

    HerrHW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology2003;61:105108.

    • Search Google Scholar
    • Export Citation
  • 6

    KonetyBRJoslynSAO'DonnellMA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol2003;169:946950.

    • Search Google Scholar
    • Export Citation
  • 7

    HerrHWFaulknerJRGrossmanHB. Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol2004;22:27812789.

    • Search Google Scholar
    • Export Citation
  • 8

    HerrHLeeCChangS. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: A collaborative group report. J Urol2004;171:18238; discussion 1827–828.

    • Search Google Scholar
    • Export Citation
  • 9

    BajorinDF: Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. J Clin Oncol2001;19:17S20S.

    • Search Google Scholar
    • Export Citation
  • 10

    SplinterTAScherHIDenisL. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer—Genitourinary Group. J Urol1992;147:606608.

    • Search Google Scholar
    • Export Citation
  • 11

    ScherHIYagodaAHerrHW. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol1988;139:470474.

    • Search Google Scholar
    • Export Citation
  • 12

    BassiPPaganoFPappagalloG. Neo-adjuvant M-VAC of invasive bladder cancer: G.U.O.N.E. multicenter phase III trial(Abstr #567). Eur Urol1998;33:142.

    • Search Google Scholar
    • Export Citation
  • 13

    WallaceDMRaghavanDKellyKA. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol1991;67:608615.

    • Search Google Scholar
    • Export Citation
  • 14

    Martinez-PineiroJAGonzalez MartinMArocenaF. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: A prospective randomized phase III study. J Urol1995;153:964973.

    • Search Google Scholar
    • Export Citation
  • 15

    ShipleyWUWinterKAKaufmanDS. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol1998;16:35763583.

    • Search Google Scholar
    • Export Citation
  • 16

    CortesiE. Neoadjuvant treatment for locally advanced bladder cancer: A prospective randomized clinical trial(Abstr #623). Proc Am Soc Clin Oncol1995;14:237.

    • Search Google Scholar
    • Export Citation
  • 17

    HallR. Updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer(Abstr #710). Proc Am Soc Clin Oncol2002;21:178a.

    • Search Google Scholar
    • Export Citation
  • 18

    GrossmanHBNataleRBTangenCM. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med2003;349:859866.

    • Search Google Scholar
    • Export Citation
  • 19

    MalmstromPURintalaEWahlqvistR. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol1996;155:19031906.

    • Search Google Scholar
    • Export Citation
  • 20

    Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet2003;361:19271934.

    • Search Google Scholar
    • Export Citation
  • 21

    BonoAVBenvenutiCRealiL. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res1989;303:533540.

    • Search Google Scholar
    • Export Citation
  • 22

    StockleMMeyenburgWWellekS. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol1992;148:302306; discussion 306–307.

    • Search Google Scholar
    • Export Citation
  • 23

    SkinnerDGDanielsJRRussellCA. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol1991;145:459464; discussion 464–467.

    • Search Google Scholar
    • Export Citation
  • 24

    StuderUEBacchiMBiedermannC. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol1994;152:8184.

    • Search Google Scholar
    • Export Citation
  • 25

    FreihaFReeseJTortiFM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol1996;155:495499; discussion 499–500.

    • Search Google Scholar
    • Export Citation
  • 26

    MillikanRDinneyCSwansonD. Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol2001;19:40054013.

    • Search Google Scholar
    • Export Citation
  • 27

    von der MaaseHHansenSWRobertsJT. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol200;18:30683077.

    • Search Google Scholar
    • Export Citation
  • 28

    DoddPMMcCaffreyJAHerrH. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol1999;17:25462552.

    • Search Google Scholar
    • Export Citation
  • 29

    DonatSMHerrHWBajorinDF. Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer. J Urol1996;156:368371.

    • Search Google Scholar
    • Export Citation
  • 30

    MillerRFreihaFReeseJ. Surgical restaging of patients with advanced transitional cell carcinoma of the urothelium treated with cisplatin, methotrexate, and vinblastine: Update of the Stanford University experience(Abstr). Proc Am Soc Clin Oncol1992;10:167.

    • Search Google Scholar
    • Export Citation
  • 31

    HerrHWDonatSMBajorinDF: Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol2001;165:811814.

    • Search Google Scholar
    • Export Citation
  • 32

    MalmstromPURintalaEWahlqvistR. Neoadjuvant cisplatin-methotrexate chemotherapy of invasive bladder cancer: Nordic cystectomy trial 2: XIVth Congress of the European Association of Urology(Abstr #238). Eur Urol1999;35(Suppl 2):60.

    • Search Google Scholar
    • Export Citation
  • 33

    Abol-EneinHEl-MekreshMEl-BazM. Neoadjuvant chemotherapy in treatment of invasive transitional bladder cancer: A controlled prospective randomized study(Abstr #191). Br J Urol1997;80(Suppl 2):49.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 25 25 1
PDF Downloads 3 3 0
EPUB Downloads 0 0 0